The University of Bristol spinout is working on adapting cell therapies to solid tumours.
Adam Perriman, professor of bioengineering at University of Bristol, is every tech transfer professional’s dream faculty member. He gained his PhD from Australian National University in 2007 – not long before the global financial crisis threw the world’s economies into turmoil – and immediately began pondering the benefits of spinouts, which were still a rarity at the time.
“Things were looking rough in 2008,” he told Global University Venturing. “I was looking at the world and realised that the west…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
